About Silo Pharma Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://silopharma.com/
Frequently Asked Questions
What is the 52-week range for SILO?
The 52-week high is $10.87 and the 52-week low is $1.4634.
What is the P/E ratio for SILO?
The P/E ratio data is currently unavailable.
What is the dividend yield for SILO?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -81.74%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -6715.72%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.72.
Analyst Recommendation Trends
Wall Street analyst consensus for SILO over the last few months:
Latest SILO News
Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting; To Buy Software And Intellectual Property From Norsight Consulting
On October 1, 2026, Silo Pharma, Inc. (the "Company") entered into an asset purchase agreement (the "Agreement") with Norsight Consulting Inc., an Arkansas corporation (the "Seller"). Pursuant to
Silo Pharma's QwikAgents Subsidiary Expands AI Agent Platform With New Client, To Support Client-Provided Nvidia API Keys, Adds Hermes Agent Runtime
Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Onconetix (NASDAQ:ONCO) stock increased by 10.3% to $1.14 during Friday's after-market session. The market value of their outstanding shares is at $3.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved
Silo Pharma Receives U.S. Patent Office Notice Of Allowance For Application Covering SPC-15, Its Novel Intranasal Therapeutic Targeting Post-Traumatic Stress Disorder
The invention, titled "Compositions and Methods for the Prevention of Stress-Induced Fear, Depressive-Like and Anxiety-Like Behavior," is also covered by a corresponding patent issued by the Japan Patent Office
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2025-12-15 | Weisblum Eric | +2,500 | $0.42 | $1,050 |
| 2025-12-15 | Weisblum Eric | +2,500 | $0.41 | $1,025 |
| 2025-11-21 | Weisblum Eric | +1,000 | $0.365 | $365 |
| 2025-11-20 | Weisblum Eric | +1,000 | $0.37 | $370 |
| 2025-11-19 | Weisblum Eric | +4,500 | $0.405 | $1,823 |
| 2025-11-18 | Weisblum Eric | +7,500 | $0.4033 | $3,025 |